Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mackler, A.M.
Right arrow Articles by Yellon, S.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackler, A.M.
Right arrow Articles by Yellon, S.M.
Agricola
Right arrow Articles by Mackler, A.M.
Right arrow Articles by Yellon, S.M.
Biology of Reproduction 62, 1193-1200 (2000)
© 2000 Society for the Study of Reproduction, Inc.


Article

Distribution and Activation of Uterine Mononuclear Phagocytes in Peripartum Endometrium and Myometrium of the Mouse

A.M. Mackler1,a, L.M. Greenc, P.J. McMilland, and S.M. Yellon1,a,b

a Center for Perinatal Biology, b Departments of Physiology, c Microbiology and Molecular Biology, and d Division of Anatomy, Loma Linda University School of Medicine, Loma Linda, California 92350


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present study tested the hypothesis that macrophage distribution and activation are enhanced in the uterus before term. Mid-uterine horn tissue strips from mice on Days 15 and 18 of pregnancy, the day of birth (= Day 19), and one day postpartum were paraffin-embedded and then sectioned, stained with a monoclonal pan-macrophage marker (BM8), and processed for visualization and quantification of resident macrophages per nuclear area. Macrophages were dispersed throughout the endometrium and subluminal epithelium; cell numbers declined on the day before term, then increased postpartum. Within myometrium, macrophages congregated in stroma surrounding muscle bundles, and staining was enhanced near term. Macrophage numbers were similar in pregnant and postpartum uteri, enhanced more than 2-fold over those in nonpregnant controls. Uterine sections were also analyzed by laser-scanning cytometry to enumerate activated macrophages (i.e., those that express the intercellular adhesion molecule marker CD54+) and to determine cell cycle (propidium iodide fluorescence). Activated macrophages were directly proportional to cell numbers and, by cell cycle analysis, were not terminally differentiated. Highest cell numbers occurred on Day 15: 4-fold greater than those in nonpregnant controls and 2-fold higher than those at Day 18 or in postpartum groups. These findings indicate a decline in endometrial macrophage numbers at least one day before the onset of parturition and raise the possibility that trafficking of this immune cell may contribute to onset of labor.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The etiology of preterm labor has been associated with enhanced immune activity within the uterus [1, 2]. In amniotic fluid and decidua, elevated concentrations of inflammatory cytokines and prostaglandins, presumably in response to infection, may contribute to the onset of premature labor. However, in the absence of infection, a rise in proinflammatory cytokine production in the uterus late in pregnancy suggests that immune reactivity may be increased and anticipate the onset of parturition [3, 4]. Specific immune cells that reside and traffic within discrete regions of the pregnant uterus may be a source of this cytokine production. Immunophenotypes, including T cells, natural killer cells, and mast cells, are present in the uterus throughout pregnancy in a variety of species [5, 6]. However, these cell types either decline in number during early pregnancy or are segregated in specific compartments at term, e.g., uterine metrial gland clusters of natural killer cells [68].

By far, the most common and widely distributed resident immune cell in the uterus is the mononuclear phagocyte. Defined as a macrophage, though some possess monocytic characteristics [5, 9], these cells are abundant in human decidua during the first and third trimesters of pregnancy [10, 11]. In the rodent, uterine macrophages are distributed throughout the pregnant endometrium, as well as in stroma and connective tissue around muscle bundles in the myometrium [6, 12]. On the basis of estimates from cell suspensions of pooled murine uteri at various stages of pregnancy, macrophages may account for nearly 10% of cells in the virgin uterus and comprise upwards of 22% of cells from the pregnant uterus [13, 14]. As confirmed by cell count estimates in tissue sections, uterine macrophage numbers appear to increase as pregnancy progresses [9]. However, a recent study of cell counts during the peripartum period has indicated that the uterine macrophage population is reduced on the day preceding birth by more than 50% from that 4 days before term [12]. This decline in macrophage numbers correlates with reduced production of inducible nitric oxide synthase (iNOS) in the uterus near term [15]. Macrophages are the major source of iNOS, a factor that promotes vasodilatation and uterine smooth muscle relaxation [16, 17].

Although loss of resident macrophages may eliminate a major restraint on uterine contractile activity, myometrial quiescence may also be lost by other means. Macrophages may traffic between endometrial and myometrial compartments, a possibility not investigated in previous studies of total numbers of resident cells [12, 14]. Alternatively, local or select activation of macrophages before the initiation of labor may modulate myometrial contractility. For example, macrophages produce specific inflammatory cytokines and prostaglandins [1820], concentrations of which are elevated in maternal circulation and amniotic fluid in association with induced preterm labor [1, 21, 22]. These findings raise the possibility that activation of resident macrophages in the peripartum myometrium may contribute to a local immune process that initiates parturition. Therefore, the goal of the present study was to test the hypothesis that enhanced numbers or activation of uterine macrophages within the myometrium precedes parturition. To address this hypothesis, macrophage distribution in the uterus and expression of CD54, an intercellular adhesion molecule (ICAM)-1 marker of macrophage activation [23], were assessed in the pregnant and postpartum uterus during the peripartum period.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animal Model

Time-dated pregnant C3N/HeN mice were obtained on Day 12 of pregnancy from Harlan Sprague Dawley, Inc. (Indianapolis, IN). Mice were killed by cervical dislocation on the morning of gestational Day 15 or 18, on the day pups were born (postpartum: Day 19 postmating), and 1 day postpartum. Strips of complete uterine tissue (approximately 2 x 5 mm) from the mesometrium between placental discs were obtained as previously described [24]. Tissue was formalin-fixed and embedded in paraffin (n = 4–9/group in duplicate). Uteri from virgin mice (nonpregnant) in the estrous phase of the reproductive cycle served as controls. In nonpregnant mice, the estrous phase of the reproductive cycle was confirmed by the presence of endometrial thickening, glandular development, and columnar epithelium following histological analysis of hematoxylin-stained uterine tissue. The experimental protocol was reviewed and approved by the Institutional Animal Care and Use Committees.

Tissue Processing and Macrophage Counts

Paraffin-embedded uterine strips were sectioned at 6 µm, then immunostained by an automated "sandwich" technique with a monoclonal pan-macrophage marker, BM8 (affinity-purified rat IgG2a antibody; Bachem Biosciences, King of Prussia, PA) [25]. As has been previously described [12, 24], this antibody produces dark, high-contrast resolution of uterine macrophages, the distribution and number of which are comparable to those in earlier studies with the F4/80 antibody [6, 14]. Tissue sections processed in the absence of primary or secondary antibody, or with a blocking antibody (Dako, Carpenteria, CA), displayed no appreciable nonspecific stain. Briefly, macrophages were enumerated by systematically counting cells in adjacent visual fields of a tissue section (every one half 10x field) using a 40x lens and a 10 x 10 grid in the ocular reticle; one section from each of the two uterine horns was analyzed for each mouse. These stereological methods preclude duplication of counts, and their implementation has been previously described [12]. Cell counts from tissue sections avoid cell loss and changes in cellular characteristics that may accompany enzyme-digested tissue suspensions; as such, macrophage numbers cannot be directly compared to those in previous reports [12, 14]. A macrophage was defined as a distinct BM8-positive soma (brown) with a hematoxylin-counterstained nucleus (blue); reaction product in pseudopodia and cellular fragments not associated with a nucleus were excluded from cell counts. Tissue boundaries, i.e., endometrium versus myometrium, were determined by histological examination. Endometrial and myometrial macrophage numbers were then calculated from BM8+ cell counts. To compensate for hypertrophy and hyperplasia associated with pregnancy, BM8+ cell counts were normalized to nuclear area as measured in digitized images (Image Pro Plus; Media Cybernetics, Silver Spring, MD). Frozen sections (20 µm) were also processed by immunohistochemistry to visualize stained macrophages for photomicrographs. Staining of splenic macrophages was used as a positive control for BM8 specificity (not shown).

Assessment of Macrophage Activation Using Laser-Scanning Cytometry (LSC)

Paraffin-embedded tissue sections immediately adjacent to those in which BM8-stained cells were enumerated, i.e., subsequent serial sections, were incubated with fluorescein isothiocyanate (FITC)-conjugated anti-CD54 monoclonal antibody (Southern Biotechnology Assoc., Inc., Birmingham, AL). As an activation marker, CD54 (ICAM-1) is expressed by macrophages, epithelium, and vascular endothelium [6, 23, 26, 27]. CD54 was also chosen as an indicator of macrophage activation because it represents a mechanism of cell-to-cell communication, as well as an indicator of cellular activity that is linked to immune surveillance and enhanced antigen presentation [23]. Numbers of positively stained cells, as well as density of expression per cell, are considered markers of activation [28, 29]. Other cell types express CD54 [3032] but are not typically present in tissue compartments within the uterus. Sections were counterstained with propidium iodine (PI) at a concentration of 50 µg/ml in PBS with 100 µg/ml ribonuclease type A (Sigma Chemical, St. Louis, MO). PI is a DNA-intercalating fluorescent stain that was used to identify nuclei from CD54-positive cells for macrophage quantification and cell cycle determination by LSC [33]. Slides were wet-mount coverslipped with Permafluor mounting solution (Lipshaw Immunon, Pittsburgh, PA). Each microscopy slide was scanned with argon-ion and helium-neon lasers, and images were digitized at 0.5-µm spatial intervals along the raster scan path. (CompuCyte, Cambridge, MA). On the basis of fluorescent light intensity, contours were automatically drawn to define individual PI-labeled objects. A minimum threshold (inclusion/exclusion gate) was defined by a contour parameter of pixel area that established the size of a standard nucleus. Settings and threshold adjustments were confirmed by visual inspection using a digital camera that was attached to the microscope. Once limits were defined, subsequent sets nearly always fell within the same range; parameters were stored in a protocol file and retrieved for all additional runs. A second integrating contour was drawn to assess intensity of PI fluorescence from objects that expressed CD54 fluorescence. Finally, a third contour was drawn to measure nonspecific background fluorescence. Background was automatically subtracted from the integrated fluorescence of CD54+ cells, a calculation based on gated channels of green fluorescence (FITC). The PI and CD54+ cell population was gated out from other cells and set up in an isolated window for cell cycle program analysis, which automatically proportioned G1, S, and G2 cell cycle components. Intensity of CD54 expression per cell was defined as green channel florescence as a proportion of total fluorescence; tissues from pregnant and nonpregnant mice were analyzed, but postpartum groups were not available for this analysis. Whether fluorescent-labeled cells were in endometrium or myometrium could not be distinguished because of analytic limitations. Cell cycle was determined by measuring intensity of PI fluorescence, an indication of chromatin condensation and nuclear size.

Statistical Analysis

Cell count data were evaluated by one-way ANOVA (SPSS, Chicago, IL). When statistically significant, individual comparisons were made using Bonferroni's test (P < 0.05 was considered significant). If Levene's test for homogeneity of variance was significant, then the Kruskal-Wallis test was used and multiple comparisons were performed.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Peripartum Uterine Histology and Macrophage Localization

The pregnant endometrium (mesometrium) was characterized by a loosely organized matrix of cells, blood vessels, and glands, juxtaposed to a tightly packed columnar epithelial cell layer at the interface of the uterine lumen (Fig. 1A). By comparison, the myometrium was a highly organized region composed of an inner layer of circular smooth muscle fascicles and an outer layer of longitudinal smooth muscle bundles. In the nonpregnant uterus, endometrial and myometrial regions were densely packed with cells (Fig. 1B).



View larger version (181K):
[in this window]
[in a new window]
 
FIG. 1. Histology of the murine uterus and resident macrophages. Photomicrograph of paraffin-embedded tissue sections (6 µm) labeled by immunocytochemistry for macrophages (indicated by arrows) with BM8 monoclonal antibody; sections were counterstained with hematoxylin. Uterine tissue is shown from A) pregnant (postpartum) and B) nonpregnant mice. Macrophages were prevalent in postpartum mesometrial endometrium (C: Day 1 postpartum); insert is magnified (4-fold, computer enlarged) endometrial macrophage with extended pseudopodia. Macrophages clustered in stroma and connective tissue between smooth muscle bundles in myometrium (D, E, F: gestational Day 15, postpartum Day 1, and gestational Day 18, respectively). E) Examples of elongated macrophage processes surround smooth muscle bundles in the postpartum myometrium (20-µm-thick frozen section). cm, Circular muscle; e, endometrium; epi, epithelium of endometrium; lm, longitudinal muscle; s, stromal myometrium. Bars indicate 100 µm in A and B or 50 µm in C–F.

In the pregnant endometrium, BM8-labeled cells were present, often adjacent to glandular or vascular tissue. Stained cells were commonly found in the endometrial stroma either associated with the subepithelial region or proximal to blood vessels (Fig. 1C; Day 15 of gestation). Though the distribution of macrophages was similar in pregnant and postpartum endometrium, as described below, fewer macrophages were observed in mice on Day 18 of pregnancy, the day before parturition.

In myometrium, labeled cells were exclusively present in connective tissue or stromal areas between the muscle fascicles or bundles (Fig. 1, D–F). On Day 15, clusters of macrophages were present between circular and longitudinal muscle layers (Fig. 1D). Specific stromal staining in cells and their processes around longitudinal muscle fascicles or circular muscle bundles was enhanced in peripartum groups (Fig. 1, E and F; postpartum Day 1 and Day 18, respectively). This network of stained cells and pseudopodia was most apparent in thick frozen tissue sections.

Peripartum Macrophage Numbers

In endometrium, macrophage numbers increased nearly 5-fold on Day 15 of pregnancy compared to those in nonpregnant controls (Fig. 2). Macrophages declined 70% by Day 18, then rebounded postpartum to levels that were not significantly different from those on Day 15 (2784 cells/mm2 of nucleus). In myometrium, macrophage numbers were also increased on Day 15 of pregnancy. Cell numbers remained elevated on the day before birth and postpartum compared to those in the nonpregnant group.



View larger version (30K):
[in this window]
[in a new window]
 
FIG. 2. Number of macrophages in the endometrium and myometrium of the mouse. Mean number of BM8+ cells (± SE) in uteri on Day 15 (d15, n = 8) or 18 of pregnancy (d18, n = 5), postpartum (PP = Day 19; n = 4), or 1 day after birth (PPd1; n = 8) relative to that in nonpregnant controls (NP; n = 9). The average number of macrophages in duplicate sections/mouse uterus was normalized to nuclear area to compensate for uterine hypertrophy during pregnancy and was expressed as percentage of total cell number relative to that in NP mice (602.6 and 280.3 macrophages/mm2 nucleus area in endometrium and myometrium, respectively). Statistical differences are indicated by "a" versus NP group or "b" versus d18 mice. See Materials and Methods for details of experimental design and statistical analyses. In myometrium, macrophage numbers on d18 were not statistically different from those in d15 or postpartum groups

Activated Macrophages in the Peripartum Uterus

CD54 was expressed by a significant number of cells in specific compartments within the uterus and in the luminal epithelium. In the nonpregnant mice, FITC-conjugated CD54+ cells were sparsely distributed in subepithelial endometrium and myometrium (Fig. 3, A and B, respectively). In the pregnant uterus, CD54+ cells were dispersed throughout the endometrium and were frequently aligned with, or adjacent to, the luminal epithelium and endothelial lining of the vasculature (Fig. 3, C and D). In pregnant and postpartum myometrial sections, CD54+ cells were most evident in the stromal regions between circular and longitudinal muscle bundles (Fig. 3, E and F, respectively). Expression of CD54 by vascular epithelium was minimal in these regions of the uterus.



View larger version (163K):
[in this window]
[in a new window]
 
FIG. 3. Photomicrographs of CD54-FITC-labeled cells (green on original) with PI counterstain (red on original) in the murine uterus. In nonpregnant mice, activated macrophages (those expressing CD54+) were present in endometrium (A) and myometrium (B). Enhanced FITC label and numbers of CD54+ cells were evident in pregnant uterus in association with the luminal epithelium (C) and in the endometrium (D). Macrophage clusters were prevalent in stroma at the interface between circular (E; gestational Day 15) and longitudinal (F; postpartum Day 1) muscle bundles in the pregnant and peripartum myometria. Arrows indicate macrophages. Abbreviations same as those in Figure 1 legend. Bar indicates 50 µm

In addition, increased numbers of resident cells expressed the activation marker CD54 during pregnancy compared to those in nonpregnant mice (Fig. 4, left). At Day 15 of pregnancy, CD54-labeled cells were significantly increased compared to those in all other groups, nearly 5-fold higher than those in uteri from nonpregnant mice. Enhanced numbers of CD54+ cells persisted through the postpartum period compared to those of nonpregnant controls. Technical limitations in the LSC analyses precluded anatomic resolution within uterine compartments of individual fluorescent cells. Although not shown, the average integrated intensity of fluorescence by individual CD54+ cells and by the luminal epithelium was increased by 50% in pregnant uteri (both gestational Day 15 and Day 18 groups) compared to those in uteri from nonpregnant mice (P < 0.05, ANOVA; tissue from postpartum groups was not available for analysis).



View larger version (33K):
[in this window]
[in a new window]
 
FIG. 4. CD54+-expressing cells in uteri from nonpregnant, pregnant, and postpartum mice (left). Cells labeled with FITC-conjugated anti-CD54 monoclonal antibody were counted by LSC. Data are the mean (± SE) numbers of CD54 cells relative to those in nonpregnant mice (4.6 ± 1% of PI-labeled cells expressed CD54 in nonpregnant mice). Cell cycle assessments of CD54+ cells (right) were based on intensity of PI counterstain, an index of nuclear chromatin condensation that distinguished among G1/G0, S, or G2/M phases. P < 0.05 indicated by "a" versus nonpregnant mice or "b" versus gestational Day 18 group. Abbreviations same as those in Figure 2 legend

Although the number of activated uterine macrophages was highest on Day 15 of pregnancy, whether a change occurred during the peripartum period in the percentage of cells that expressed CD54 relative to total number of macrophages remained to be determined. BM8+ cells that were labeled with CD54+ could not be directly assessed since separate serial tissue sections were analyzed by different methods, i.e., brightfield microscopy for BM8 and LSC for CD54. To address the question of percentage of activated macrophages present in the peripartum uterus, CD54+ cell number/mm2 of nucleus for each tissue section was estimated and then normalized to density of nuclei to correct for variations in uterine hypertrophy across groups. These CD54 cell number estimates were divided by BM8+ cell count/mm2 of nucleus. In nonpregnant uteri, CD54+ cells represented approximately 45% of the total number of BM8-stained cells. By contrast, 25% of the total number of BM8-stained cells expressed CD54 in uteri from mice on Day 15 of pregnancy and in postpartum groups. However, on Day 18, the day before birth, CD54 cells represented 60% of BM8-labeled cell numbers. These estimates provide an indication that activation in the macrophage population peaks on the day before birth.

The proportion of cells double-labeled with FITC and PI in various stages of the cell cycle did not vary with respect to reproductive status. Cell cycle analysis across groups indicated that approximately half of the CD54+ cells were in S phase, i.e., actively synthesizing DNA (Fig. 4, right). Of the remaining double-labeled cells, 40% were in G0/G1 phase, recently divided cells or non-DNA synthesizing, while 10% were in mitosis, in G2/M phase. Thus, activated uterine macrophages in nonpregnant, pregnant, and postpartum groups were in a comparable state of proliferation and were not terminally differentiated.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The immunological paradox of fetal allograft survival focuses attention on the diverse roles that the maternal immune system plays in the suppression of fetal allograft rejection [3436], as well as in the regulation of trophoblast invasion [9] and fertility [37, 38]. The initial hypothesis that an increase in the number of activated uterine macrophages precedes parturition was not supported by the present findings.

Rather, numbers of activated macrophages in the endometrium were diminished on the day before birth. The loss of endometrial macrophages may signify a divestiture of cells that contribute to immune suppression and uterine quiescence during gestation. This loss could be due to emigration or death of a select population of macrophages. Remaining macrophages, those that reside in the myometrium, may shift the balance of activity to produce inflammatory factors that promote uterine contractile activity. Thus, the data raise the possibility that loss of a critical number or subset of macrophages, accompanied by activation of macrophages that remain in the uterus, is part of the process of parturition.

The results of this study extend previous reports that indicate macrophage numbers are increased during the quiescent phase that characterizes the majority of pregnancy [9, 12, 14]. Peak numbers occur after the midpoint of gestation, around Day 12 in the mouse [14]. On Day 15 of gestation, labeled macrophages are still present in high numbers in both the endometrium and myometrium compared to those in the nonpregnant uterus, particularly in association with uterine epithelium, glandular tissue, and stroma between smooth muscle bundles. Numbers of activated macrophages—cells expressing the activation marker CD54—demonstrate changes parallel to total macrophage numbers. Thus at this stage of pregnancy, enhanced numbers of activated macrophages correspond temporally to elevated iNOS production in the uterus in other rodents [15, 39, 40]. Since iNOS promotes uterine quiescence, the present study provides support for the hypotheses by Buhimschi et al. [16] and others [15, 17] that enhanced production of iNOS may restrain uterine contractile activity at this stage of pregnancy [24]. Furthermore, these data focus attention on the possibility that this inhibitory mechanism involves a macrophage population that principally resides in the endometrium.

As pregnancy nears conclusion, endometrial macrophage numbers decline, but a stable population is maintained in the myometrium. These data raise the possibility that macrophage depletion from the endometrium may account for decreased iNOS production at term [15]. Thus, emigration or death of uterine macrophages may remove a mechanism that promotes uterine quiescence. Eliminating an impediment to uterine activity does not itself explain why contractile activity is enhanced at term in the mouse [24].

Since macrophages in the myometrium are sustained at high numbers relative to those in nonpregnant mice, it is conceivable that resident myometrial macrophages may shift activities towards production of inflammatory mediators that enhance local contractile capabilities. Macrophage processes appear to surround or envelop individual muscle bundles to a greater extent before and after the day of birth than on Day 15 of pregnancy [12]. Throughout this period, a high percentage of activated macrophages are in S phase of the cell cycle; i.e., they are proliferative and not terminally differentiated. This finding is congruent with other studies that described monocyte-like cells or resident macrophages as proliferative in various tissues [41, 42] and capable of cell division in the uterus [5, 9]. Whether a subset of activated macrophages is proliferating on Day 18 and contributes to enhanced uterine contractility just before the onset of labor cannot be excluded from consideration.

Use of two independent methods to count cells precludes direct analysis of activation marker expression by an individual macrophage. However, a preliminary indication based upon the number with CD54 fluorescence per tissue area suggests that a greater percentage of macrophages were activated on Day 18, the day before birth. These activated immunophenotypes are presumably in the myometrium since fewer cells reside in the endometrium on day of pregnancy. As an activation marker, enhanced CD54 expression is thought to facilitate extravasation of leukocytes into areas of inflammation by the binding of CD54 to the integrin, leukocyte function-associated antigen-1 [43, 44]. Whether an interaction between activated macrophages and other constituent cells in endometrium or myometrium may regulate cytokine production at the appropriate time during pregnancy is not known, but synthesis of interferon {gamma} and tumor necrosis factor {alpha}, potent inflammatory mediators, is increased in the murine uterus at term [4, 9, 45]. Since the macrophage is known to produce such inflammatory cytokines and prostaglandins [18, 45, 46], the findings raise the possibility that resident macrophages may influence uterine contractile activity at term.

After birth, macrophage numbers increase in the postpartum uterus. Immigration of macrophages into the evacuated uterus is likely to restore elevated macrophage numbers in the postpartum endometrium. Macrophages are found in the vicinity of the detachment wound in the uterus, known as the postpartum nodule, for up to 3 mo [47]. Influx of these cells is suggested to participate in wound healing, tissue repair, and the restoration of the uterus to the nonpregnant state in preparation for the next cycle of postpartum estrus. Infiltration of leukocytes into the human myometrium follows the onset of labor [48]. However, continued proliferation (50% of CD54 cells were in S phase) also suggests that cell division may temporally coincide with increased macrophage numbers in the aftermath of parturition.

In summary, at the conclusion of pregnancy, the macrophage is proposed to be important for the shift from immune suppression, associated with the majority of pregnancy, to inflammatory immune activity at the onset of labor [4, 5, 9]. This study provides evidence of a modified distribution of macrophages in the uterus before and after birth. A decline in the number of activated macrophages in the endometrium, but not myometrium, on the day before birth suggests that withdrawal of these immune cells may participate in an escape from contractile inhibition at term. One destination for immigration of endometrial macrophages may be the cervix, to facilitate relaxation there, because the population of this immunophenotype increases in the cervix on the day before birth [12]. At the same time, an established, and perhaps transformed, number of activated macrophages in the myometrium raises the possibility that this subpopulation of cells may contribute to amplification of contractile activity that culminates in the onset of labor. Thus, the process of parturition in the mouse may be characterized as a transition from quiescence to inflammation associated, in part, with a shift in the uterine macrophage population at term.


    ACKNOWLEDGMENTS
 
The authors thank Mary North, Conrad Daniels, and technical staff in the Laboratory of Clinical Pathology for training and expert guidance. Additionally, we would like to thank Jocelyn C. Bennett and Long Tran for help in data acquisition, graphics, and analyses.


    FOOTNOTES
 
First decision: 6 August 1999.

1 Correspondence. FAX: 909 824 4029; syellon{at}som.llu.edu Back

Accepted: December 13, 1999.

Received: June 22, 1999.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Fidel PL Jr, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, Cotton DB. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170:1467–1475.[Medline]
  2. Dudley DJ, Chen CL, Branch DW, Hammond E, Mitchell MD. A murine model of preterm labor: inflammatory mediators regulate the production of prostaglandin E2 and interleukin-6 by murine decidua. Biol Reprod 1993; 48:33–39.[Abstract]
  3. Opsjon S, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Waage A, Austgulen R. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169:397–404.[Medline]
  4. Platt JS, Hunt JS. Interferon {gamma} gene expression in cycling and pregnant mouse uterus: temporal aspects and cellular localization. J Leukocyte Biol 1998; 64:393–400.[Abstract]
  5. Padykula HA, Tansey TR. The occurrence of uterine stromal and intraepithelial monocytes and heterophils during normal late pregnancy in the rat. Anat Rec 1979; 193:329–356.[CrossRef][Medline]
  6. Hunt JS. Immunologically relevant cells in the uterus. Biol Reprod 1994; 50:461–466.[Abstract]
  7. Vassiliadou N, Bulmer JN. Quantitative analysis of T lymphocyte subsets in pregnant and nonpregnant human endometrium. Biol Reprod 1996; 55:1017–1022.[Abstract]
  8. Delgado SR, McBey BA, Yamashiro S, Fujita J, Kiso Y, Croy BA. Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus. J Leukocyte Biol 1996; 59:262–269.[Abstract]
  9. Yelavarthi KK, Chen HL, Yang YP, Cowley BD Jr, Fishback JL, Hunt JS. Tumor necrosis factor-alpha mRNA and protein in rat uterine and placental cells. J Immunol 1991; 146:3840–3848.[Abstract]
  10. Bulmer JN, Johnson PM. Macrophage populations in the human placenta and amniochorion. Clin Exp Immunol 1984; 57:393–403.[Medline]
  11. Bulmer JN. Decidual cellular responses. Curr Opin Immunol 1989; 1:1141–1147.[CrossRef][Medline]
  12. Mackler AM, Iezza G, Akin MR, McMillan PJ, Yellon SM. Macrophage trafficking in uterus and cervix precedes parturition in the mouse. Biol Reprod 1999; 61:879–883.[Abstract/Free Full Text]
  13. Hunt JS, Manning LS, Mitchell D, Selanders JR, Wood GW. Localization and characterization of macrophages in murine uterus. J Leukocyte Biol 1985; 38:255–265.[Abstract]
  14. De M, Wood GW. Analysis of the number and distribution of macrophages, lymphocytes, and granulocytes in the mouse uterus from implantation through parturition. J Leukocyte Biol 1991; 50:381–392.[Abstract]
  15. Hunt JS, Miller L, Vassmer D, Croy BA. Expression of the inducible nitric oxide synthase gene in mouse uterine leukocytes and potential relationships with uterine function during pregnancy. Biol Reprod 1997; 57:827–836.[Abstract]
  16. Buhimschi I, Yallampalli C, Dong YL, Garfield RE. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 1995; 172:1577.[CrossRef][Medline]
  17. Yallampalli C, Buhimschi I, Chwalisz K, Garfield RE, Dong YL. Preterm birth in rats produced by the synergistic action of a nitric oxide inhibitor (NG-nitro-L-arginine methyl ester) and an antiprogestin (onapristone). Am J Obstet Gynecol 1996; 175:207–212.[CrossRef][Medline]
  18. Norwitz ER, Starkey PM, Lopez Bernal A, Turnbull AC. Identification by flow cytometry of the prostaglandin-producing cell populations of term human decidua. J Endocrinol 1991; 131:327–334.[Abstract/Free Full Text]
  19. Eis AL, Brockman DE, Myatt L. Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes. Am J Reprod Immunol 1997; 38:289–294.
  20. Kim YJ, Ahn JJ, Woo BH. The effect of cytokine mediators on prostaglandin inhibition by human decidual cells. Am J Obstet Gynecol 1998; 179:146–149.[CrossRef][Medline]
  21. Romero R, Mazor M, Tartakovsky B. Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991; 165:969–971.[Medline]
  22. Franchi A, Motta A, Farina M, Rivero ML, Ogando D, Gimeno M. Effect of IL-1{alpha} on prostaglandin synthesis of oestrogenized rat uterus is mediated by nitric oxide. Prostaglandins Leukot Essent Fatty Acids 1998; 58:413–416.[CrossRef][Medline]
  23. Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W. Markers of mouse macro-phage development detected by monoclonal antibodies. J Immunol Methods 1994; 174:5–19.[CrossRef][Medline]
  24. Mackler AM, Ducsay CA, Veldhuis JD, Yellon SM. Maturation of spontaneous and agonist-induced uterine contractions in the peripartum mouse uterus. Biol Reprod 1999; 61:873–878.[Abstract/Free Full Text]
  25. Malorny U, Michels E, Sorg C. A monoclonal antibody against an antigen present on mouse macrophages and absent from monocytes. Cell Tissue Res 1986; 243:421–428.[Medline]
  26. Goebeler M, Roth J, Kunz M, Sorg C. Expression of intercellular adhesion molecule-1 by murine macrophages is up-regulated during differentiation and inflammatory activation. Immunobiology 1993; 188:159–171.[Medline]
  27. Ruck P, Marzusch K, Kaiserling E, Horny HP, Dietl J, Geiselhart A, Handgretinger R, Redman CW. Distribution of cell adhesion molecules in decidua of early human pregnancy. An immunohistochemical study. Lab Invest 1994; 71:94–101.[Medline]
  28. Fattal-German M, Ladurie FL, Cerrina J, Lecerf F, Berrih-Aknin S. Modulation of ICAM-1 expression in human alveolar macrophages in vitro. Eur Respir J 1996; 9:463–471.[Abstract]
  29. Salafia CM, Kagey-Sobotka A, Lichtenstein, LM, Bochner BS. Immunophenotyping and functional analysis of purified human uterine mast cells. Blood 1992; 79:708–712.[Abstract/Free Full Text]
  30. Guo CB, Kagey-Sobotka A, Lichtenstein LM, Bochner BS. Immunophenotyping and functional analysis of purified human uterine mast cells. Blood 1992; 79:708–712.
  31. Slukvin II, Chernyshov VP, Merkulova AA, Vodyanik MA, Kalinovsky AK. Differential expression of adhesion and homing molecules by human decidual and peripheral blood lymphocytes in early pregnancy. Cell Immunol 1994; 158:29–45.[CrossRef][Medline]
  32. Calatayud S, Vivier E, Bernaud J, Merieux Y, Rigal D. Expression of NK cell-restricted epitope on decidual large granular lymphocytes. Int Immunol 1996; 8:1637–1642.[Abstract/Free Full Text]
  33. Kamentsky LA, Burger DE, Gershman RJ, Kamentsky LD, Luther E. Slide-based laser scanning cytometry. Acta Cytol 1997; 41:123–143.[Medline]
  34. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353–356.[CrossRef][Medline]
  35. Buhimschi I, Ali M, Jain V, Chwalisz K, Garfield RE. Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 1996; 11:1755–1766.[Abstract/Free Full Text]
  36. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191–1193.[Abstract/Free Full Text]
  37. Hunt JS. Cytokine networks in the uteroplacental unit: macrophages as pivotal regulatory cells. J Reprod Immunol 1989; 16:1–17.[CrossRef][Medline]
  38. Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 1991; 148:273–283.[CrossRef][Medline]
  39. Yallampalli C, Byam-Smith M, Nelson SO, Garfield RE. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 1994; 13:1971–1974.
  40. Dong YL, Fang L, Gangula PRR, Yallampalli C. Regulation of inducible nitric oxide synthase messenger ribonucleic acid expression n pregnant rat uterus Biol Reprod 1998; 59:933–940.[Abstract/Free Full Text]
  41. Goto M, Matsuno K, Yamaguchi Y, Ezaki T, Ogawa M. Proliferation kinetics of macrophage subpopulations in a rat experimental pancreatitis model. Arch Histol Cytol 1993; 56:75–82.[Medline]
  42. Lan HY, Nikolic-Paterson DJ, Mu W, Atkins RC. Local macrophage proliferation in multinucleated giant cell and granuloma formation in experimental Goodpasture's syndrome. Am J Pathol 1995; 147:1214–1220.[Abstract]
  43. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987; 51:813–819.[CrossRef][Medline]
  44. Meyer DM, Dustin ML, Carron CP. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol 1995; 155:3578–3584.[Abstract]
  45. De M, Sanford TH, Wood GW. Detection of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in the uterus during the second half of pregnancy in the mouse. Endocrinology 1992; 131:14–20.[Abstract/Free Full Text]
  46. Steinborn A, von Gall C, Hildenbrand R, Stutte HJ, Kaufmann M. Identification of placental cytokine-producing cells in term and preterm labor. Obstet Gynecol 1998; 91:329–335.[CrossRef][Medline]
  47. Brandon JM. Distribution of macrophages in the mouse uterus from one day to three months after parturition, as defined by the immunohistochemical localization of the macrophage-restricted antigens F4/80 and macrosialin. Anat Rec 1994; 240:233–242.[CrossRef][Medline]
  48. Thomson AJ, Telfer JF, Young A, Campbell S, Stewart CJR, Cameron IT, Greer IA, Norman JE. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 1999; 14:229–236.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
ReproductionHome page
L. J Oliveira and P J Hansen
Deviations in populations of peripheral blood mononuclear cells and endometrial macrophages in the cow during pregnancy
Reproduction, October 1, 2008; 136(4): 481 - 490.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. S.-Y. Leong, J. E. Norman, and R. Smith
Vascular and Myometrial Changes in the Human Uterus at Term
Reproductive Sciences, January 1, 2008; 15(1): 59 - 65.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
L. S. Kirby, M. A. Kirby, J. W. Warren, L. T Tran, and S. M. Yellon
Increased Innervation and Ripening of the Prepartum Murine Cervix
Reproductive Sciences, December 1, 2005; 12(8): 578 - 585.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
A. M. Mackler, T. C. Ducsay, C. A. Ducsay, and S. M. Yellon
Effects of Endotoxin and Macrophage-Related Cytokines on the Contractile Activity of the Gravid Murine Uterus
Biol Reprod, October 1, 2003; 69(4): 1165 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
S. M. Yellon, A. M. Mackler, and M. A. Kirby
The Role of Leukocyte Traffic and Activation in Parturition
Reproductive Sciences, September 1, 2003; 10(6): 323 - 338.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
K. Tsuboi, A. Iwane, S. Nakazawa, Y. Sugimoto, and A. Ichikawa
Role of Prostaglandin H2 Synthase 2 in Murine Parturition: Study on Ovariectomy-Induced Parturition in Prostaglandin F Receptor-Deficient Mice
Biol Reprod, July 1, 2003; 69(1): 195 - 201.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mackler, A.M.
Right arrow Articles by Yellon, S.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackler, A.M.
Right arrow Articles by Yellon, S.M.
Agricola
Right arrow Articles by Mackler, A.M.
Right arrow Articles by Yellon, S.M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS